Immunomodulating drugs for chronic lymphocytic leukaemia.

  title={Immunomodulating drugs for chronic lymphocytic leukaemia.},
  author={Asher Alban Chanan-Khan and Carl W. Porter},
  journal={The Lancet. Oncology},
  volume={7 6},
Chronic lymphocytic leukaemia (CLL) is a malignant haematological disorder that remains mostly incurable; more than 95% of patients have disease of B-cell origin. Advances with targeted agents such as monoclonal antibodies, antisense therapy, or both these techniques combined with traditional chemotherapy have improved the frequency of remission. The… CONTINUE READING